NewHydrogen, Inc.
For the period ended Jun 30, 2026. Filed Aug 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 3, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-05-15.
0001493152-26-023744
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-08-03.
0001493152-26-035837
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 43 previous paragraphs and 55 current paragraphs.
29 unchanged; 11 reworded; 14 added; 3 removed; 0 previous and 1 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (14)
Current report
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires incremental disclosures about specific expense categories, including but not limited to, purchases of inventory, employee compensation, depreciation, amortization and selling expenses. The amendments are effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted and the amendments may be applied either prospectively or retrospectively. The Company is currently evaluating this ASU to determine its impact on the Company’s disclosures. The amendments only impact disclosures and are not expected to have an impact on the Company’s financial condition and results of operations.
Current report
The Company considers all new pronouncements and management has determined that there have been no recently adopted or issued accounting standards that had or will have a material impact on its financial statements.
Current report
Results of Operations – Six months ended June 30, 2026, compared to the Six months ended June 30, 2025.
Current report
OPERATING EXPENSES
Current report
Selling and Marketing Expenses
Current report
S&M expenses increased by $2,876 to $203,447 for the six months ended June 30, 2026, compared to $200,571 for the prior period ended June 30, 2025. The primary reason for the increase in S&M expenses was due to an increase in website development offset by a decrease in ad campaigns.
Current report
General and Administrative Expenses
Current report
G&A expenses increased by $212,610 to $861,116 for the six months ended June 30, 2026, compared to $648,506 for the prior period ended June 30, 2025. The majority of the increase related to an increase in stock compensation expense for a vesting amendment and an increase in audit fees. These increases were offset by decreases to legal fees and market fees.
Current report
Research and Development
Current report
R&D expenses increased by $425,002 to $674,387 for the six months ended June 30, 2026, compared to $249,385 for the prior period ended June 30, 2025. This overall increase in R&D expenses was the result of an increase in research agreement costs, and consultant costs.
Current report
Depreciation and Amortization Expense
Current report
Depreciation and amortization expense for the six months ended June 30, 2026 and 2025 was $1,642 and $1,641, respectively.
Current report
Net Loss
Current report
During the six months ended June 30, 2026, we received $763,035 in cash for financing activities as compared to $0 for the prior period ended June 30, 2025. Cash received during the current period was for shares issued through an equity financing agreement.
Removed paragraphs (3)
Previous report
Management reviewed currently issued pronouncements during the three months ended March 31, 2026, and does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed unaudited financial statements.
Previous report
Other Income/(Expenses)
Previous report
Other income and (expenses) decreased by $472 to ($295) for the three months ended March 31, 2026, compared to $177 for the prior period ended March 31, 2025. The decrease in other income and (expenses) was the result of a decrease in interest income of $73 and other expenses of $399 in the current period.
Reworded paragraphs (11)
Previous wording
The preparation of financial statements in conformity with generally accepted accounting principles, requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements, include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, derivative liabilities and the fair value of stock options. Actual results could differ from those estimates.
Current wording
The preparation of financial statements in conformity with generally accepted accounting principles, requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements, include the estimate of useful lives of property and equipment, the deferred tax valuation allowance and the fair value of stock options. Actual results could differ from those estimates.
Previous wording
Our cash, cash equivalents, investments, inventory, prepaid expenses, and accounts payable are stated at cost which approximates fair value due to the short-term nature of these instruments.
Current wording
Our cash, cash equivalents, prepaid expenses, and accounts payable are stated at cost which approximates fair value due to the short-term nature of these instruments.
Previous wording
Selling and marketing (“S&M”) expenses decreased by $12,910 to $93,569 for the three months ended March 31, 2026, compared to $106,479 for the prior period ended March 31, 2025. The primary decrease in S&M expenses was the result of a decrease in spending on advertising and marketing.
Current wording
Selling and marketing (“S&M”) expenses increased by $15,786 to $109,878 for the three months ended June 30, 2026, compared to $94,092 for the prior period ended June 30, 2025. The primary increase in S&M expenses was the result of an increase in spending on website development and marketing.
Previous wording
General and administrative (“G&A”) expenses increased by $129,345 to $396,798 for the three months ended March 31, 2026, compared to $267,453 for the prior period ended March 31, 2025. The overall increase was an increase in insurance expense.
Current wording
General and administrative (“G&A”) expenses increased by $83,265 to $464,318 for the three months ended June 30, 2026, compared to $381,053 for the prior period ended June 30, 2025. The majority of the increase related to increased stock option expense for a vesting amendment, increased accounting fees and an increase due to timing of market fees.
Previous wording
Research and Development (“R&D”) expenses increased by $229,995 to $331,513 for the three months ended March 31, 2026, compared to $101,518 for the prior period ended March 31, 2025. This overall increase in R&D expenses was the result of an increase in consultant costs.
Current wording
Research and Development (“R&D”) expenses increased by $195,007 to $342,874 for the three months ended June 30, 2026, compared to $147,867 for the prior period ended June 30, 2025. This overall increase in R&D expenses was the result of an increase in research agreement costs, and consultant costs.
Previous wording
Depreciation and amortization expense for the three months ended March 31, 2026 and 2025 was $821 and $821, respectively.
Current wording
Depreciation and amortization expense for the three months ended June 30, 2026 and 2025 was $821 and $820, respectively.
Previous wording
Our net loss for the three months ended March 31, 2026 was $822,996, compared to $476,094 for the prior period ended March 31, 2025. The Company has not generated any revenues. The majority of the increase in net loss was due to an overall increase in operating expenses and non-cash expense associated with the net change in stock option expense in the current period. These estimates were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs were subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the stock options fluctuate, and the fluctuation may be material. The Company has not generated any revenues.
Current wording
Our net loss for the three months ended June 30, 2026 was $917,822, compared to $623,704 for the prior period ended June 30, 2025. The Company has not generated any revenues. The majority of the increase in net loss was due to an overall increase in operating expenses and non-cash expense associated with the net change in stock option expense in the current period. The estimates for stock compensation expense were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs were subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the stock options fluctuate, and the fluctuation may be material.
Previous wording
The accompanying unaudited condensed financial statements as of March 31, 2026, have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying unaudited condensed financial statements do not reflect any adjustments that might result if we are unable to continue as a going concern. During the three months ended March 31, 2026, we did not generate any revenues, and recognized a net loss of $822,996, due to a change in operating expenses and cash of $722,587 used in operations. As of March 31, 2026, we had working capital of $751,663 and a shareholders’ deficit of $2,718,350.
Current wording
The accompanying unaudited condensed financial statements as of June 30, 2026, have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying unaudited condensed financial statements do not reflect any adjustments that might result if we are unable to continue as a going concern. During the six months ended June 30, 2026, we did not generate any revenues, and recognized a net loss of $1,740,818, due to a change in operating expenses and cash of $1,460,435 used in operations. As of June 30, 2026, we had working capital of $788,355 and a shareholders’ deficit of $2,643,279.
Previous wording
As of March 31, 2026, we had working capital of $751,663 compared to $1,433,163 for the year ended December 31, 2025. This decrease in working capital was due primarily to a decrease in cash.
Current wording
As of June 30, 2026, we had working capital of $788,355 compared to $1,433,163 for the year ended December 31, 2025. This decrease in working capital was due primarily to a decrease in cash.
Previous wording
During the three months ended March 31, 2026, we used $722,587 in cash for operating activities, as compared to $492,812 for the prior period ended March 31, 2025. The increase in the use of cash for operating activities for the current period was a result of an increase in research and development cost, and advertising and marketing.
Current wording
During the six months ended June 30, 2026, we used $1,460,435 in cash for operating activities, as compared to $1,003,615 for the prior period ended June 30, 2025. The increase in the use of cash for operating activities for the current period was a result of an increase in research and development, and general and administrative costs.
Previous wording
There was no investing or financing activities during the three months ended March 31, 2026 and March 31, 2025.
Current wording
There was no investing activities during the six months ended June 30, 2026 and June 30, 2025.
Rearranged current paragraphs (1)
Current report — wording carried from elsewhere
Our net loss for the six months ended June 30, 2026 was $1,740,818, compared to $1,099,798 for the prior period ended June 30, 2025. The Company has not generated any revenues. The majority of the increase in net loss was due to an overall increase in operating expenses and non-cash expense associated with the net change in stock option expense in the current period. The estimates for stock compensation expense were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs were subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the stock options fluctuate, and the fluctuation may be material.